Lv1
60 积分 2025-04-18 加入
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers
18天前
已完结
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans
28天前
已完结
Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis — Past, Present, and Future
2个月前
已完结
JAK inhibitor: Introduction
2个月前
已完结
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model
2个月前
已关闭
Update on tocilizumab in rheumatoid arthritis: a narrative review
2个月前
已关闭
Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events
2个月前
已完结
Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase–dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes
2个月前
已完结
RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease
2个月前
已完结
Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury
2个月前
已完结
皖公网安备34019202002308
